2021
DOI: 10.1016/j.phytochem.2021.112713
|View full text |Cite
|
Sign up to set email alerts
|

Beta-lapachone: Natural occurrence, physicochemical properties, biological activities, toxicity and synthesis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
12
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 32 publications
(12 citation statements)
references
References 60 publications
0
12
0
Order By: Relevance
“…Two compounds, Active1 and Active2, exhibited a strong activity against flagella-associated functions in the primary screen and might represent active patho-blocker compounds. Active1, which also had very strong antibacterial effects on H. pylori , belonged to the family of β-lapachones, which have been described as canonical strong antibacterial natural compounds from Lapacho tree bark active on various bacterial species and parasites long ago ( 41 46 ). One validated cellular (metabolic) target of β-lapachone is the NAD(P)H:quinone oxidoreductase-1 (NQO1) subunit of membrane respiratory complex I ( 47 ), which has led to the proposition of using lapachones in a variety of indications, including the treatment of tumors, parasites, fungi or bacterial infections, as its target is ubiquitous and essential in bacteria ( 46 ).…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Two compounds, Active1 and Active2, exhibited a strong activity against flagella-associated functions in the primary screen and might represent active patho-blocker compounds. Active1, which also had very strong antibacterial effects on H. pylori , belonged to the family of β-lapachones, which have been described as canonical strong antibacterial natural compounds from Lapacho tree bark active on various bacterial species and parasites long ago ( 41 46 ). One validated cellular (metabolic) target of β-lapachone is the NAD(P)H:quinone oxidoreductase-1 (NQO1) subunit of membrane respiratory complex I ( 47 ), which has led to the proposition of using lapachones in a variety of indications, including the treatment of tumors, parasites, fungi or bacterial infections, as its target is ubiquitous and essential in bacteria ( 46 ).…”
Section: Resultsmentioning
confidence: 99%
“…Active1, which also had very strong antibacterial effects on H. pylori , belonged to the family of β-lapachones, which have been described as canonical strong antibacterial natural compounds from Lapacho tree bark active on various bacterial species and parasites long ago ( 41 46 ). One validated cellular (metabolic) target of β-lapachone is the NAD(P)H:quinone oxidoreductase-1 (NQO1) subunit of membrane respiratory complex I ( 47 ), which has led to the proposition of using lapachones in a variety of indications, including the treatment of tumors, parasites, fungi or bacterial infections, as its target is ubiquitous and essential in bacteria ( 46 ). We performed direct motility (taxis) assays with Active1, which strongly inhibited motility and targeted motility at low concentrations after short exposure times ( Fig.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…LPC is a pleiotropic natural product, which has attracted much attention because of its strong antitumor activity in a variety of tumors ( Gomes et al, 2021 ; Gong et al, 2021 ). LPC has limited therapeutic use because of its narrow treatment window, poor water solubility and high toxicity ( Gomes et al, 2021 ).…”
Section: Discussionmentioning
confidence: 99%
“…LPC is a pleiotropic natural product, which has attracted much attention because of its strong antitumor activity in a variety of tumors ( Gomes et al, 2021 ; Gong et al, 2021 ). LPC has limited therapeutic use because of its narrow treatment window, poor water solubility and high toxicity ( Gomes et al, 2021 ). At present, a large number of studies focus on ameliorating the defects of LPC itself through formulation improvement or structural modification optimization, which makes it possible to regain clinical application ( Blanco et al, 2007 ; Park et al, 2016 ; Jardim et al, 2017 ).…”
Section: Discussionmentioning
confidence: 99%